Rt. Patel et al., AUTOANTIBODY PREVALENCE AND ASSOCIATION IN INFLAMMATORY BOWEL-DISEASE, European journal of gastroenterology & hepatology, 6(8), 1994, pp. 705-709
Objective: To study the prevalence and correlation of the following an
tibodies with disease activity: antineutrophil cytoplasmic antibodies
(ANCA), anti-endothelial cell antibodies (AECA) and anti-epithelial ce
ll (anti-EPI) antibodies. Patients and methods: Sera from the followin
g patients were tested: 41 patients with ulcerative colitis, 30 patien
ts with ulcerative colitis following restorative proctocolectomy (RPC)
, 30 patients with Crohn's disease, 10 disease controls, and 34 health
y controls. Results: ANCA were found in 65 patients (64%) [31 with ulc
erative colitis (76%); 21 with ulcerative colitis following RPC (70%);
13 with Crohn's disease (43%)]. AECA were found in 33 patients (33%)
[15 with ulcerative colitis (37%); 12 with ulcerative colitis followin
g RPC (40%); six with Crohn's disease (20%)] and anti-EPI antibodies i
n 20 patients (20%) [six with ulcerative colitis (15%); six with ulcer
ative colitis following RPC (20%); eight with Crohn's disease (27%)].
A strong association between ANCA and both AECA (P= 0.0001) and anti-E
PI antibodies (P= 0.003) was noted. Significant cross-reactivity was n
oted between ANCA and anti-EPI antibodies (P=0.0001), but not between
ANCA and AECA (P=0.09) following removal of ANCA from the sera (adsorp
tion) by isolated neutrophils fixed on microtitre plates. The prevalen
ce of these autoantibodies did not correlate with either disease activ
ity or treatment. Conclusion: All antibodies persisted despite total c
olectomy, indicating that these antibodies do not merely reflect colon
ic inflammation. The cross-reactivity of ANCA with anti-EPI antibodies
could be an important factor which may help to explain the high preva
lence of ANCA in ulcerative colitis.